By Frank Prenesti
Date: Monday 11 Sep 2023
LONDON (ShareCast) - (Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.
Gyroscope was sold to Novartis in February last year in $1.5bn deal, with Syncona receiving $442m (£326m) for its stake.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 96.40p |
Change Today | 0.60p |
% Change | 0.63 % |
52 Week High | 125.80p |
52 Week Low | 79.70p |
Volume | 194,448 |
Shares Issued | 607.86m |
Market Cap | £585.98m |
Beta | 0.05 |
RiskGrade | 291 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 21-Jun-18 | 20-Jul-17 |
Paid | 30-Jul-18 | 23-Aug-17 |
Amount | 2.30p | 2.30p |
Time | Volume / Share Price |
16:35 | 12,728 @ 96.40p |
16:35 | 771 @ 96.40p |
16:35 | 338 @ 96.40p |
16:35 | 142 @ 96.40p |
16:35 | 300 @ 96.40p |
You are here: research